Description
Labradimil, Arg-Pro-Hyp-Gly-Thi-Ser-Pro-Tyr(Me)-psi(CH₂NH)-Arg, is a selective bradykinin B₂ receptor agonist with a longer plasma half-life than bradykinin. Labradimil transiently increases the permeability of the blood-brain barrier (BBB) to facilitate delivery of drugs to the CNS.



